<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Although prophylactic treatment with beta-blockers is used to retard <z:hpo ids='HP_0002616'>aortic root dilatation</z:hpo> in <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e>, it is not effective in <z:hpo ids='HP_0000001'>all</z:hpo> patients </plain></SENT>
<SENT sid="1" pm="."><plain>To assess the effects of beta-adrenergic blockade on the aorta's elastic properties, aortic stiffness index and distensibility were calculated in 13 patients with <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> and 10 control subjects before and after beta-adrenergic blockade </plain></SENT>
<SENT sid="2" pm="."><plain>At baseline, patients with <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> had a significantly increased stiffness index and decreased distensibility </plain></SENT>
<SENT sid="3" pm="."><plain>After beta-adrenergic blockade, 8 patients with <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> developed stiffness indexes and distensibility values that were closer to <z:mpath ids='MPATH_458'>normal</z:mpath>, whereas these variables deteriorated in 5 patients </plain></SENT>
<SENT sid="4" pm="."><plain>Thus the benefit of beta-adrenergic blockade in <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> may be the reduction in pulse pressure and myocardial contractility and also promotion of the elastic properties of the aorta </plain></SENT>
<SENT sid="5" pm="."><plain>Moreover, the differential responses of aortic mechanics (normalizing or worsening) to beta-adrenergic blockade may possibly have implications for the prognosis in these patients </plain></SENT>
</text></document>